These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Time-dependent inactivation of aromatase by 6-alkylandrosta-1,4-diene-3,17-diones. Effects of length and configuration of 6-alkyl group. Numazawa M, Oshibe M, Yamaguchi S, Tachibana M. J Med Chem; 1996 Mar 01; 39(5):1033-8. PubMed ID: 8676338 [Abstract] [Full Text] [Related]
3. Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione. Takahashi M, Handa W, Umeta H, Ishikawa S, Yamashita K, Numazawa M. J Steroid Biochem Mol Biol; 2009 Sep 01; 116(3-5):191-9. PubMed ID: 19520161 [Abstract] [Full Text] [Related]
5. Synthesis and structure-activity relationships of 6-phenylaliphatic-substituted C19 steroids having a 1,4-diene, 4,6-diene, or 1,4,6-triene structure as aromatase inhibitors. Numazawa M, Yamaguchi S. Steroids; 1999 Mar 01; 64(3):187-96. PubMed ID: 10400379 [Abstract] [Full Text] [Related]
6. Probing the binding pocket of the active site of aromatase with 6-ether or 6-ester substituted androst-4-ene-3,17-diones and their diene and triene analogs. Numazawa M, Shelangouski M, Nagasaka M. Steroids; 2000 Dec 01; 65(12):871-82. PubMed ID: 11077085 [Abstract] [Full Text] [Related]
7. Studies directed towards a mechanistic evaluation of inactivation of aromatase by the suicide substrates androsta-1,4-diene-3,17-diones and its 6-ene derivatives aromatase inactivation by the 19-substituted derivatives and their enzymic aromatization. Numazawa M, Nagaoka M, Handa W, Ogawa Y, Matsuoka S. J Steroid Biochem Mol Biol; 2007 Dec 01; 107(3-5):211-9. PubMed ID: 17656084 [Abstract] [Full Text] [Related]
8. 6-Phenylaliphatic-substituted androst-4-ene-3,17-diones as aromatase inhibitors: structure-activity relationships. Numazawa M, Yamaguchi S. J Steroid Biochem Mol Biol; 1998 Oct 01; 67(1):41-8. PubMed ID: 9780028 [Abstract] [Full Text] [Related]
10. 6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships. Numazawa M, Oshibe M, Yamaguchi S. Steroids; 1997 Oct 01; 62(8-9):595-602. PubMed ID: 9292934 [Abstract] [Full Text] [Related]
14. Steroidal metabolites transformed by Marchantia polymorpha cultures block breast cancer estrogen biosynthesis. Hegazy ME, Gamal-Eldeen AM, El-Halawany AM, Mohamed Ael-H, Paré PW. Cell Biochem Biophys; 2012 May 01; 63(1):85-96. PubMed ID: 22350385 [Abstract] [Full Text] [Related]
15. Probing the active site of aromatase with 2-methyl-substituted androstenedione analogs. Numazawa M, Watari Y, Yamada K, Umemura N, Handa W. Steroids; 2003 Aug 01; 68(6):503-13. PubMed ID: 12906935 [Abstract] [Full Text] [Related]
18. Enzymic aromatization of 6-alkyl-substituted androgens, potent competitive and mechanism-based inhibitors of aromatase. Numazawa M, Yoshimura A, Oshibe M. Biochem J; 1998 Jan 01; 329 ( Pt 1)(Pt 1):151-6. PubMed ID: 9405288 [Abstract] [Full Text] [Related]
19. Synthesis and aromatase inhibitory activity of some new 16E-arylidenosteroids. Bansal R, Thota S, Karkra N, Minu M, Zimmer C, Hartmann RW. Bioorg Chem; 2012 Dec 01; 45():36-40. PubMed ID: 23064126 [Abstract] [Full Text] [Related]